Jacobi Capital Management LLC Intercept Pharmaceuticals, Inc. Transaction History

Jacobi Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$14.28 - $19.53 $8,568 - $11,718	-600 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$24.48 - $42.47 $14,688 - $25,482	-600 Reduced 50.0%	600 $15,000
Q2 2020 Aug 04, 2020	BUY	$46.7 - $92.04 $55,479 - $109,343	1,188 Added 9900.0%	1,200 $57,000
Q2 2020 Jul 27, 2020	SELL	$46.7 - $92.04 $55,479 - $109,343	-1,188 Reduced 99.0%	12 $57,000
Q1 2020 Apr 24, 2020	SELL	$48.35 - $118.68 $48,350 - $118,680	-1,000 Reduced 45.45%	1,200 $76,000
Q4 2019 Feb 03, 2020	SELL	$57.36 - $124.1 $57,360 - $124,100	-1,000 Reduced 31.25%	2,200 $273,000
Q2 2019 Aug 07, 2019	BUY	$77.77 - $120.68 $248,864 - $386,176	3,200 New	3,200 $255,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Jacobi Capital Management LLC with notifications on news.